title: Subcutaneous apomorphine for neuroleptic malignant syndrome.
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Lattanzi
authors.forename: Francesco
authors.initials: F
authors.lastname: Mungai
authors.forename: Anna
authors.initials: A
authors.lastname: Romano
authors.forename: Ubaldo
authors.initials: U
authors.lastname: Bonuccelli
authors.forename: Giovanni B
authors.initials: GB
authors.lastname: Cassano
authors.forename: Andrea
authors.initials: A
authors.lastname: Fagiolini
mesh_terms: D001058:Apomorphine / Q000008:administration & dosage* / Q000627:therapeutic use; D018491:Dopamine Agonists / Q000008:administration & dosage* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D018491:Dopamine Agonists; D001058:Apomorphine